A Tale of Two Reopenings, With and Without the Union Label
American Shakespeare Center and Berkshire Theatre Group will soon open full-scale productions, but only one has Actors’ Equity’s approval.
Stories by Jerald Raymond Pierce
Jerald Raymond Pierce is the associate editor of American Theatre. He studied acting at Ohio University and received his M.A. in arts journalism from Syracuse University. A member of the American Theatre Critics Association, he is also a freelance reviewer for the Chicago Tribune. Follow him on Twitter and Instagram @TheJRPierce.
Not a Moment but a Movement: Toward an Anti-Racist American Theatre
The collective that started by saying ‘We See You, White American Theater’ makes its own demands to be seen, and fully included, at last.
Tired but Not Daunted in the Twin Cities
Amid the grief and rage over George Floyd’s murder, but unable to gather and heal through their art, Black theatremakers speak out and demand change.
Chay Yew: Break the Table and Build a New One
After 9 years at Victory Gardens, the writer/director reflects on what he’s learned from running, and fighting for, a theatre in Chicago.
Theatres Make, and Unmake, Their Summer Plans
As Utah Shakes’s summer season shutters, theatres from Missouri to Massachusetts weigh alternatives to staying dark for the rest of 2020.
The Actor’s Life Goes On, Minus a Script
The pandemic shutdown is a crushing blow for theatres, but it is individual artists who are absorbing the brunt of the pain.
Theatre by Any Other Name
Beyond simply streaming filmed stage productions, artists are getting creative in connecting with audiences and each other in a quarantined world.
Streams Before the Flood?
Streaming and video-captured options for shuttered shows could be more than a stopgap solution.
U.S. Theatres Reel and Regroup in Face of Closures
As Broadway shutters to prevent the spread of coronavirus, the nation’s small and regional theatres follow suit—and enter a time of grave uncertainty.
Theatres Stay Open but Make Backup Plans Amid COVID-19 Concerns
Even in disease hotspots, most U.S. theatres are taking a wait-and-see approach to the public health risks of live performance.
